Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Net Loss Per Share (Tables)

v3.23.3
Note 7 - Net Loss Per Share (Tables)
9 Months Ended
Sep. 30, 2023
Notes Tables  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
   

For the Three and Nine Months Ended

 
   

September 30,

 
   

2023

   

2022

 

Unvested restricted stock units/awards

    98,137       13,145  

Warrants

    6,078,132        

Options

    1,685,000        

Class A Preferred shares

    16,666       16,666  

Total potential dilutive effect

    7,877,935       29,811